Molecular mechanisms of resistance in epidermal growth factor receptor-mutant lung adenocarcinomas

被引：117

作者：

Cortot, Alexis B. ^{[1
,2
]}

Jaenne, Pasi A. ^{[3
]}

机构：

[1] Univ Lille Nord France, Lille Univ Hosp, Hop Calmette, Thorac Oncol Dept, Lille, France

[2] Univ Lille 1, Inst Biol Lille, UMR8161, Siric OncoLille, Lille, France

[3] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA

来源：

EUROPEAN RESPIRATORY REVIEW | 2014年 / 23卷 / 133期

关键词：

D O I：

10.1183/09059180.00004614

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The discovery of epidermal growth factor receptor (EGFR) mutations in nonsmall cell lung cancer (NSCLC) has allowed the identification of a subset of patients whose tumours are exquisitely sensitive to EGFR tyrosine kinase inhibitors (TKIs). Despite the efficacy and superiority of EGFR TKIs over chemotherapy as first-line therapy, all patients will ultimately develop progressive disease, with a median of 9-13 months progression-free survival. A better understanding of the molecular mechanisms underlying resistance to EGFR TKIs can help design new drugs and therapeutic strategies to overcome resistance. This has been illustrated by the new generation TKIs that are effective on the T790M mutation, which is the most frequent mechanism of acquired resistance to EGFR TKIs. In this article, we will address the main molecular mechanisms of primary and acquired resistance to EGFR TKIs in EGFR-mutant NSCLC.

引用

页码：356 / 366

页数：11

共 88 条

[21] Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor [J].

Ercan, D. ;

Zejnullahu, K. ;

Yonesaka, K. ;

Xiao, Y. ;

Capelletti, M. ;

Rogers, A. ;

Lifshits, E. ;

Brown, A. ;

Lee, C. ;

Christensen, J. G. ;

Kwiatkowski, D. J. ;

Engelman, J. A. ;

Jaenne, P. A. .

ONCOGENE, 2010, 29 (16) :2346-2356

[22] Reactivation of ERK Signaling Causes Resistance to EGFR Kinase Inhibitors [J].

Ercan, Dalia ;

Xu, Chunxiao ;

Yanagita, Masahiko ;

Monast, Calixte S. ;

Pratilas, Christine A. ;

Montero, Joan ;

Butaney, Mohit ;

Shimamura, Takeshi ;

Sholl, Lynette ;

Ivanova, Elena V. ;

Tadi, Madhavi ;

Rogers, Andrew ;

Repellin, Claire ;

Capelletti, Marzia ;

Maertens, Ophelia ;

Goetz, Eva M. ;

Letai, Anthony ;

Garraway, Levi A. ;

Lazzara, Matthew J. ;

Rosen, Neal ;

Gray, Nathanael S. ;

Wong, Kwok-Kin ;

Jaenne, Pasi A. .

CANCER DISCOVERY, 2012, 2 (10) :934-947

[23] Non-Small Cell Lung Cancer, Version 2.2013 Featured Updates to the NCCN Guidelines [J].

Ettinger, David S. ;

Akerley, Wallace ;

Borghaei, Hossein ;

Chang, Andrew C. ;

Cheney, Richard T. ;

Chirieac, Lucian R. ;

D'Amico, Thomas A. ;

Demmy, Todd L. ;

Govindan, Ramaswamy ;

Grannis, Frederic W., Jr. ;

Grant, Stefan C. ;

Horn, Leora ;

Jahan, Thierry M. ;

Komaki, Ritsuko ;

Kong, Feng-Ming ;

Kris, Mark G. ;

Krug, Lee M. ;

Lackner, Rudy P. ;

Lennes, Inga T. ;

Loo, Billy W., Jr. ;

Martins, Renato ;

Otterson, Gregory A. ;

Patel, Jyoti D. ;

Pinder-Schenck, Mary C. ;

Pisters, Katherine M. ;

Reckamp, Karen ;

Riely, Gregory J. ;

Rohren, Eric ;

Shapiro, Theresa A. ;

Swanson, Scott J. ;

Tauer, Kurt ;

Wood, Douglas E. ;

Yang, Stephen C. ;

Gregory, Kristina ;

Hughes, Miranda .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (06) :645-653

[24] Src Mediates Cigarette Smoke-Induced Resistance to Tyrosine Kinase Inhibitors in NSCLC Cells [J].

Filosto, Simone ;

Baston, David S. ;

Chung, Samuel ;

Becker, Cathleen R. ;

Goldkorn, Tzipora .

MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) :1579-1590

[25] Cigarette Smoke Induces Aberrant EGF Receptor Activation That Mediates Lung Cancer Development and Resistance to Tyrosine Kinase Inhibitors [J].

Filosto, Simone ;

Becker, Cathleen R. ;

Goldkorn, Tzipora .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) :795-804

[26] EGF Receptor Exposed to Oxidative Stress Acquires Abnormal Phosphorylation and Aberrant Activated Conformation That Impairs Canonical Dimerization [J].

Filosto, Simone ;

Khan, Elaine M. ;

Tognon, Emiliana ;

Becker, Cathleen ;

Ashfaq, Majid ;

Ravid, Tommer ;

Goldkorn, Tzipora .

PLOS ONE, 2011, 6 (08)

[27] Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report [J].

Girard, Nicolas ;

Lou, Emil ;

Azzoli, Christopher G. ;

Reddy, Rekha ;

Robson, Mark ;

Harlan, Megan ;

Orlow, Irene ;

Yatabe, Yasushi ;

Nafa, Khedoudja ;

Ladanyi, Marc ;

Viale, Agnes ;

Kris, Mark G. ;

Riely, Gregory ;

Miller, Vincent ;

Klein, Robert J. ;

Matsuo, Keitaro ;

Pao, William .

CLINICAL CANCER RESEARCH, 2010, 16 (02) :755-763

[28] The T790M "gatekeeper" mutation in EGFR mediates resistance to low concentrations of an irreversible EGFR inhibitor [J].

Godin-Heymann, Nadia ;

LlIkus, Lindsey ;

Brannigan, Brian W. ;

McDermott, Ultan ;

Lamb, Jennifer ;

Maheswaran, Shyamala ;

Settleman, Jeffrey ;

Haber, Daniel A. .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (04) :874-879

[29] Induction of BIM is essential for apoptosis triggered by EGFR kinase inhibitors in mutant EGFR-dependent lung adenocarcinomas [J].

Gong, Yixuan ;

Somwar, Romel ;

Politi, Katerina ;

Balak, Marissa ;

Chmielecki, Juliann ;

Jiang, Xuejun ;

Pao, William .

PLOS MEDICINE, 2007, 4 (10) :1655-1668

[30] Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer [J].

Jackman, David ;

Pao, William ;

Riely, Gregory J. ;

Engelman, Jeffrey A. ;

Kris, Mark G. ;

Jaenne, Pasi A. ;

Lynch, Thomas ;

Johnson, Bruce E. ;

Miller, Vincent A. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :357-360

← 1 2 3 4 5 6 7 8 9 →